We are the experts in:
Recombinant proteins & Antibodies
Batavia End-To-End Solutions
We provide a personalized approach, focusing on the optimal process for your biopharmaceutical product.
Batavia is currently in the transition from a CDMO that could assist its clients in R&D and clinic manufacturing only, to now, a “one-stop-shop” where it will be able to support clients from concept product idea all the way to full market launch and commercial manufacturing (expected to be operational by the end of 2024).
And these are the results:
experts with industry experience
projects successfully completed
successful runs under GMP
Discover the power of collaboration and start a conversation to bring your innovative therapies to patients.